Browse the detailed record of transactions filed by Bernstein Harold. Officer active across 1 company, notably Maze Therapeutics, Inc.. Aggregated, 26 filings have been logged. Split: 0 buy · 14 sells. Total volume traded: €1.9m. History available since 29 December 2025. The latest transaction was disclosed on 4 September 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bernstein Harold
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Bernstein Harold is a declarant linked to Maze Therapeutics, Inc. on XNAS, where he is President, R&D & CMO. He has 16 filings in total, and in the recent sampled filings, the transactions consist of option exercises and sales for EUR 709399 between 2025-12-31 and 2026-07-02.